Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UNIPROT:P04141 (
granulocyte-macrophage colony-stimulating factor
)
6,790
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
The tissue destruction seen in chronic periodontitis is commonly accepted to involve extensive upregulation of the host inflammatory response.
Protease-activated receptor 2
(
PAR-2
)-null mice infected with Porphyromonas gingivalis did not display periodontal bone resorption in contrast to wild-type-infected and PAR-1-null-infected mice. Histological examination of tissues confirmed the lowered bone resorption in
PAR-2
-null mice and identified a substantial decrease in mast cells infiltrating the periodontal tissues of these mice. T cells from P. gingivalis-infected or immunized
PAR-2
-null mice proliferated less in response to antigen than those from wild-type animals. CD90 (Thy1.2) expression on CD4(+) and CD8(+) T-cell-receptor beta (TCRbeta) T cells was significantly (P < 0.001) decreased in antigen-immunized
PAR-2
-null mice compared to sham-immunized
PAR-2
-null mice; this was not observed in wild-type controls. T cells from infected or antigen-immunized
PAR-2
-null mice had a significantly different Th1/inflammatory cytokine profile from wild-type cells: in particular, gamma interferon, interleukins (interleukin-2, -3, and -17),
granulocyte-macrophage colony-stimulating factor
, and tumor necrosis factor alpha demonstrated lower expression than wild-type controls. The absence of
PAR-2
therefore appears to substantially decrease T-cell activation and the Th1/inflammatory response. Regulation of such proinflammatory mechanisms in T cells and mast cells by
PAR-2
suggests a pivotal role in the pathogenesis of the disease.
...
PMID:Protease-activated receptor 2 has pivotal roles in cellular mechanisms involved in experimental periodontitis. 1993 35